Treatment of AD dementia research hub

A Phase 2a/2b Randomized, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of MK-1942 as Adjunctive Therapy in Participants with Mild to Moderate Alzheimer’s Disease Dementia

This study is looking into a new medication called MK-1942 for people with mild to moderate Alzheimer's disease. Researchers want to see if it's safe and if it helps with memory and thinking. Half the people will get the new medicine, and half will get a dummy pill.